400 related articles for article (PubMed ID: 20193276)
41. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
42. β-blockers for infantile hemangiomas: a single-institution experience.
Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
[TBL] [Abstract][Full Text] [Related]
43. [Treatment of infantile subglottic hemangioma with oral propranolol].
Tang LX; Zhang YM; Wang GX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 47(9):735-8. PubMed ID: 23141442
[TBL] [Abstract][Full Text] [Related]
44. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
[TBL] [Abstract][Full Text] [Related]
45. [Propranolol for the treatment of severe hemangiomas of infancy: results from a series of 28 patients].
Bernabeu-Wittel J; Pereyra-Rodríguez JJ; Mantrana-Bermejo ME; Fernández-Pineda I; de Agustín JC; Conejo-Mir J
Actas Dermosifiliogr; 2011 Sep; 102(7):510-6. PubMed ID: 21514550
[TBL] [Abstract][Full Text] [Related]
46. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol.
Sondhi V; Patnaik SK
J Pediatr Hematol Oncol; 2013 Oct; 35(7):493-9. PubMed ID: 23929318
[TBL] [Abstract][Full Text] [Related]
47. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
48. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
49. [Preliminary clinical study on the treatment of severe infantile hemangioma with high-dose propranolol in China].
Zhan MK; Xie YD; Guo ZH; Huang BR; Zhou YK; Chen XS; Li M; Yang YC
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):166-9. PubMed ID: 21837992
[TBL] [Abstract][Full Text] [Related]
50. Large Doses of Propranolol for the Treatment of Infantile Cephalic and Facial Hemangiomas: A Clinical Report of 38 Cases.
Jianguo K; Xichun W; Mingkun Z; Qiaoling C; Wenjin L
J Clin Pediatr Dent; 2015; 39(3):268-71. PubMed ID: 26208073
[TBL] [Abstract][Full Text] [Related]
51. Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study.
Malik MA; Menon P; Rao KL; Samujh R
J Pediatr Surg; 2013 Dec; 48(12):2453-9. PubMed ID: 24314186
[TBL] [Abstract][Full Text] [Related]
52. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas.
Maturo S; Hartnick C
Int J Pediatr Otorhinolaryngol; 2010 Mar; 74(3):323-5. PubMed ID: 20071038
[TBL] [Abstract][Full Text] [Related]
53. [Subsequent therapy for infantile hemangiomas after discontinuation of oral propranolol].
Tai MZ; Liu XJ; Qin ZP; Ge CX; Li KL; Chen T
Shanghai Kou Qiang Yi Xue; 2015 Dec; 24(6):716-20. PubMed ID: 27063125
[TBL] [Abstract][Full Text] [Related]
54. Propranolol for the treatment of subglottic hemangiomas.
Raol N; Metry D; Edmonds J; Chandy B; Sulek M; Larrier D
Int J Pediatr Otorhinolaryngol; 2011 Dec; 75(12):1510-4. PubMed ID: 21944056
[TBL] [Abstract][Full Text] [Related]
55. Propranolol treatment for infantile hemangiomas.
Buckmiller LM
Curr Opin Otolaryngol Head Neck Surg; 2009 Dec; 17(6):458-9. PubMed ID: 19858718
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.
Mazereeuw-Hautier J; Hoeger PH; Benlahrech S; Ammour A; Broue P; Vial J; Ohanessian G; Léauté-Labrèze C; Labenne M; Vabres P; Rössler J; Bodemer C
J Pediatr; 2010 Aug; 157(2):340-2. PubMed ID: 20488455
[TBL] [Abstract][Full Text] [Related]
57. Treatment of alarming head and neck infantile hemangiomas with interferon-α2a: a clinical study in eleven consecutive patients.
Zhang L; Zheng JW; Yuan WE
Drug Des Devel Ther; 2015; 9():723-7. PubMed ID: 25678777
[TBL] [Abstract][Full Text] [Related]
58. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
59. Propranolol for airway hemangiomas: case report of novel treatment.
Buckmiller L; Dyamenahalli U; Richter GT
Laryngoscope; 2009 Oct; 119(10):2051-4. PubMed ID: 19650125
[TBL] [Abstract][Full Text] [Related]
60. Topical propranolol cream in treatment of superficial infantile hemangiomas: a literature review and 4 years of clinical experience.
Kovačević M; Lukinović Škudar V; Maričić G; Krnjević-Pezić G; Stanimirović A
Acta Dermatovenerol Alp Pannonica Adriat; 2014; 23(4):75-8. PubMed ID: 25527040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
